Compare · AXP vs CELZ
AXP vs CELZ
Side-by-side comparison of American Express Company (AXP) and Creative Medical Technology Holdings Inc. (CELZ): market cap, price performance, sector, and recent activity on the wire.
Summary
- AXP operates in Finance, while CELZ operates in Health Care - the two are in different parts of the market.
- AXP is the larger of the two at $214.98B, about 53127.0x CELZ ($4.0M).
- AXP has been more active in the news (26 items in the past 4 weeks vs 4 for CELZ).
- AXP has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- American Express Company
- Creative Medical Technology Holdings Inc.
- Price
- -
- -
- Market cap
- $214.98B
- $4.0M
- 1M return
- +2.13%
- -
- 1Y return
- -10.25%
- -
- Industry
- Finance: Consumer Services
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 26
- 4
- Recent ratings
- 25
- 1
American Express Company
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Latest AXP
- More Consumers Say They Plan to Shop Small® This Holiday Season Ahead of Small Business Saturday®
- American Express and Marriott Bonvoy® Expand Canadian Card Portfolio with New No-Annual-Fee Card and Enhanced Benefits
- Fanatics Unveils the Fanatics American Express® Card with 500+ Athlete Trading Card Designs and Rewards Built for Sports Fans
- Chairman and CEO Squeri Stephen J exercised 299,401 shares at a strike of $148.45 and sold $99,448,560 worth of shares (299,401 units at $332.16) (SEC Form 4)
- SEC Form 13F-HR filed by American Express Company
- EQUINOX ANNOUNCES HOUSE OF EQUINOX, AN IMMERSIVE EXPLORATION OF ALIVENESS
- Chairman and CEO Squeri Stephen J was granted 74,850 employee stock options (SEC Form 4)
- Chief Legal Officer Seeger Laureen exercised 69,860 shares at a strike of $148.45 and sold $22,925,956 worth of shares (69,860 units at $328.17), increasing direct ownership by 0.00% to 9,002 units (SEC Form 4)
- Pres., Enterprise Shared Serv. Pickett Denise was granted 17,465 employee stock options (SEC Form 4)
- Group Pres., GMNS Marrs Anna exercised 44,910 shares at a strike of $148.45 and sold $14,694,719 worth of shares (44,910 units at $327.20), decreasing direct ownership by 0.00% to 20,509 units (SEC Form 4)
Latest CELZ
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- SEC Form 10-Q filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
- President & CEO Warbington Timothy was granted 1,000,000 shares (SEC Form 4)
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
- SEC Form 10-Q filed by Creative Medical Technology Holdings Inc.